Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes.

Pande M, Hur J, Hong Y, Backus C, Hayes JM, Oh SS, Kretzler M, Feldman EL.

Diabetes. 2011 Jul;60(7):1981-9. doi: 10.2337/db10-1541. Epub 2011 May 26.

2.

Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes.

Hinder LM, Vivekanandan-Giri A, McLean LL, Pennathur S, Feldman EL.

J Endocrinol. 2013 Jan 2;216(1):1-11. doi: 10.1530/JOE-12-0356. Print 2013 Jan.

3.

Gene expression microarray analysis of the sciatic nerve of mice with diabetic neuropathy.

Zhang L, Qu S, Liang A, Jiang H, Wang H.

Int J Mol Med. 2015 Feb;35(2):333-9. doi: 10.3892/ijmm.2014.2011. Epub 2014 Nov 26.

4.

Mouse models of diabetic neuropathy.

Sullivan KA, Hayes JM, Wiggin TD, Backus C, Su Oh S, Lentz SI, Brosius F 3rd, Feldman EL.

Neurobiol Dis. 2007 Dec;28(3):276-85. Epub 2007 Jul 31.

5.

The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes.

Hur J, Dauch JR, Hinder LM, Hayes JM, Backus C, Pennathur S, Kretzler M, Brosius FC 3rd, Feldman EL.

Diabetes. 2015 Sep;64(9):3294-304. doi: 10.2337/db15-0133. Epub 2015 May 15.

6.

The identification of gene expression profiles associated with progression of human diabetic neuropathy.

Hur J, Sullivan KA, Pande M, Hong Y, Sima AA, Jagadish HV, Kretzler M, Feldman EL.

Brain. 2011 Nov;134(Pt 11):3222-35. doi: 10.1093/brain/awr228. Epub 2011 Sep 16.

7.

Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome.

Nowicki M, Kosacka J, Serke H, Blüher M, Spanel-Borowski K.

J Neurosci Res. 2012 Jan;90(1):122-31. doi: 10.1002/jnr.22728. Epub 2011 Sep 14.

PMID:
21919033
8.

Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy.

Hinder LM, Vincent AM, Hayes JM, McLean LL, Feldman EL.

Exp Neurol. 2013 Jan;239:102-10. doi: 10.1016/j.expneurol.2012.10.002. Epub 2012 Oct 8.

9.

Thymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic mice.

Wang L, Chopp M, Szalad A, Liu Z, Lu M, Zhang L, Zhang J, Zhang RL, Morris D, Zhang ZG.

Neurobiol Dis. 2012 Dec;48(3):546-55. doi: 10.1016/j.nbd.2012.08.002. Epub 2012 Aug 10.

10.

Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone.

Makino H, Miyamoto Y, Sawai K, Mori K, Mukoyama M, Nakao K, Yoshimasa Y, Suga S.

Diabetes. 2006 Oct;55(10):2747-56.

11.

Gene expression profiles displayed by peripheral blood mononuclear cells from patients with type 2 diabetes mellitus focusing on biological processes implicated on the pathogenesis of the disease.

Manoel-Caetano FS, Xavier DJ, Evangelista AF, Takahashi P, Collares CV, Puthier D, Foss-Freitas MC, Foss MC, Donadi EA, Passos GA, Sakamoto-Hojo ET.

Gene. 2012 Dec 15;511(2):151-60. doi: 10.1016/j.gene.2012.09.090. Epub 2012 Oct 2.

PMID:
23036710
12.

Diabetic neuropathy in db/db mice develops independently of changes in ATPase and aldose reductase. A biochemical and immunohistochemical study.

Bianchi R, Marelli C, Marini P, Fabris M, Triban C, Fiori MG.

Diabetologia. 1990 Mar;33(3):131-6.

PMID:
2158468
13.

Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy.

Toth C, Rong LL, Yang C, Martinez J, Song F, Ramji N, Brussee V, Liu W, Durand J, Nguyen MD, Schmidt AM, Zochodne DW.

Diabetes. 2008 Apr;57(4):1002-17. Epub 2007 Nov 26. Retraction in: Diabetes. 2014 May;63(5):1817.

14.

Latanoprost effectively ameliorates glucose and lipid disorders in db/db and ob/ob mice.

Wang G, Xu X, Yao X, Zhu Z, Yu L, Chen L, Chen J, Shen X.

Diabetologia. 2013 Dec;56(12):2702-12. doi: 10.1007/s00125-013-3032-8. Epub 2013 Aug 29.

PMID:
23989723
15.

The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration.

Bogdanov P, Corraliza L, Villena JA, Carvalho AR, Garcia-Arumí J, Ramos D, Ruberte J, Simó R, Hernández C.

PLoS One. 2014 May 16;9(5):e97302. doi: 10.1371/journal.pone.0097302. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e106227.

16.

Mouse models of diabetic neuropathy.

O'Brien PD, Sakowski SA, Feldman EL.

ILAR J. 2014;54(3):259-72. doi: 10.1093/ilar/ilt052. Review.

17.

Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.

Wang L, Chopp M, Szalad A, Liu Z, Bolz M, Alvarez FM, Lu M, Zhang L, Cui Y, Zhang RL, Zhang ZG.

Neuroscience. 2011 Oct 13;193:399-410. doi: 10.1016/j.neuroscience.2011.07.039. Epub 2011 Jul 27.

18.

Transcriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality.

Wilson KD, Li Z, Wagner R, Yue P, Tsao P, Nestorova G, Huang M, Hirschberg DL, Yock PG, Quertermous T, Wu JC.

PLoS One. 2008 Jul 9;3(7):e2609. doi: 10.1371/journal.pone.0002609.

19.

Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice.

Loffler M, Bilban M, Reimers M, Waldhäusl W, Stulnig TM.

J Pharmacol Exp Ther. 2006 Feb;316(2):797-804. Epub 2005 Oct 31.

20.

Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.

Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, Feldman EL.

Diabetes. 2009 Oct;58(10):2376-85. doi: 10.2337/db09-0047. Epub 2009 Jul 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk